Literature DB >> 3689625

Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action.

K J Hogg1, R S Hornung, C A Howie, W S Hillis.   

Abstract

1. The haemodynamic effects of ibopamine, an oral dopamine derivative, were studied in eight patients with left ventricular dysfunction using invasive catheterisation techniques. 2. An early rise was seen in the mean right atrial pressure (P less than 0.05), the mean capillary wedge pressure (P less than 0.01) and the mean pulmonary arterial pressure (P less than 0.001) which occurred at 15 min and persisted for 30 min. 3. A second, later, positive chronotropic effect was seen as an increase in the heart rate (P less than 0.05) at 45 min with an increased cardiac output (P less than 0.05) persisting above baseline values at 1 h, but with no change in stroke volume. 4. These results support a biphasic mode of action for ibopamine which may be explained by a time phase difference in alpha- and beta-adrenoceptor stimulatory effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689625      PMCID: PMC1386304          DOI: 10.1111/j.1365-2125.1987.tb03195.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

Review 1.  Dopamine--clinical uses of an endogenous catecholamine.

Authors:  L I Goldberg
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

2.  Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema.

Authors:  W D Bussmann; D Schupp
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

3.  Haemodynamic effects of prenalterol in patients with coronary heart disease.

Authors:  I Hutton; R G Murray; R N Boyes; A P Rae; W S Hillis
Journal:  Br Heart J       Date:  1980-02

4.  Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris.

Authors:  E Montani; M O Triulzi; G C Maggi
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Effects of dopamine and alpha-methyl-dopamine on smooth muscle and on the cardiac pacemaker.

Authors:  T H Tsai; S Z Langer; U Trendelenburg
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

6.  Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.

Authors:  N A Klein; S J Siskind; W H Frishman; E H Sonnenblick; T H LeJemtel
Journal:  Am J Cardiol       Date:  1981-07       Impact factor: 2.778

7.  Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.

Authors:  C V Leier; P T Heban; P Huss; C A Bush; R P Lewis
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

8.  Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment.

Authors:  J Col; E Mievis; M Reynaert
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Effect of ibopamine on diuresis and arterial blood pressure in anesthetized rats and its interactions with dopaminergic and alpha- and beta-adrenergic antagonists.

Authors:  R Ferrini; G Miragoli
Journal:  Arzneimittelforschung       Date:  1986-02

10.  Long-term digitalis therapy improves left ventricular function in heart failure.

Authors:  S B Arnold; R C Byrd; W Meister; K Melmon; M D Cheitlin; J D Bristow; W W Parmley; K Chatterjee
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

View more
  4 in total

1.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

Review 2.  Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  J M Henwood; P A Todd
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Acute effect of ibopamine and isosorbide mononitrate on blood volume distribution in congestive heart failure.

Authors:  N D Holman; O S Hoekstra; A B Groeneveld; A J Schneider; W G de Voogt; J van der Meer
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 4.  Ibopamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in congestive heart failure.

Authors:  C Spencer; D Faulds; A Fitton
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.